A61J1/12

Intravenous fluid warmer using uniform thermal field

A heating cabinet for IV bags provides a uniform thermal field promoted by circulated heated air passing through air permeable shelves. Temperatures of the IV bags are modeled through a knowledge of a temperature of the uniform thermal field and arrival time of the IV bags eliminating a need for separate temperature sensors and control loops. Bag status may be signaled through modulated light distinguishable by individuals with limited color sensitivity. Signals are associated with particular IV bags by projecting the light of the signals into the IV bags themselves.

Intravenous fluid warmer using uniform thermal field

A heating cabinet for IV bags provides a uniform thermal field promoted by circulated heated air passing through air permeable shelves. Temperatures of the IV bags are modeled through a knowledge of a temperature of the uniform thermal field and arrival time of the IV bags eliminating a need for separate temperature sensors and control loops. Bag status may be signaled through modulated light distinguishable by individuals with limited color sensitivity. Signals are associated with particular IV bags by projecting the light of the signals into the IV bags themselves.

Thin film cell encapsulation devices

Thin film devices, e.g., multilayer thin film devices, that encapsulate cells for transplantation into a subject are provided. Also provided are methods of using and methods of preparing the subject devices. The thin film devices include a first porous polymer layer and a second porous polymer layer that define a lumen therebetween and encapsulate a population of cells within the lumen. The thin film devices can promote vascularization into the lumen of the device via the pores in the first polymer layer and/or second polymer layer; limit foreign body response to the device; limit ingress of cells, immunoglobulins, and cytokines into the lumen via the first and the second polymer layers; and release from the first polymer layer and/or the second polymer layer molecules secreted by the population of cells.

FLOW PATH SEALING STRUCTURE, BAG-SHAPED CONTAINER, AND METHOD OF MANUFACTURING THE SAME
20220203628 · 2022-06-30 ·

A flow path sealing structure according to at least one embodiment of the present disclosure, which is disposed on a way of a flow path formed by fusion bonding a pair of resin sheets that are superimposed on each other, includes a widened portion surrounded by a widened seal portion formed by fusion bonding together the pair of resin sheets around a periphery thereof, and one end and another end of which are in communication with the flow path, together with being formed to be wider than the flow path, and a weakly sealed portion formed to extend in a widthwise direction in the widened portion, and which partitions the widened portion in a liquid-tight and airtight manner into the one end and the other end, together with being capable of being opened by increasing an internal pressure of the widened portion.

FLOW PATH SEALING STRUCTURE, BAG-SHAPED CONTAINER, AND METHOD OF MANUFACTURING THE SAME
20220203628 · 2022-06-30 ·

A flow path sealing structure according to at least one embodiment of the present disclosure, which is disposed on a way of a flow path formed by fusion bonding a pair of resin sheets that are superimposed on each other, includes a widened portion surrounded by a widened seal portion formed by fusion bonding together the pair of resin sheets around a periphery thereof, and one end and another end of which are in communication with the flow path, together with being formed to be wider than the flow path, and a weakly sealed portion formed to extend in a widthwise direction in the widened portion, and which partitions the widened portion in a liquid-tight and airtight manner into the one end and the other end, together with being capable of being opened by increasing an internal pressure of the widened portion.

INTRADERMAL DRUG DELIVERY DEVICE
20220193385 · 2022-06-23 · ·

An intradermal fluid delivery device that uses a processor controlled electromechanical delivery mechanism is provided. An air pump pushes fluid containing medication or saline from a fluid compartment through a microneedle array into a person's skin. The processor repeatedly turns the air pump on or off, for the fluid to gradually be injected into the person's skin. The processor may be configured to control the total fluid delivery time as well as the granularity of the fluid delivery. The total fluid delivery time may be set to T, and the time period T may be divided into smaller periods t.sub.1 to t.sub.n, where the fluid may be administered in a period t1, the fluid delivery may then be stopped for a period t2, followed by another fluid delivery period, etc. The periods t1 to tn may be the same or of different lengths.

PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT

The present disclosure relates to a sterile medical product for parenteral nutrition comprising a polymeric container having at least a first and a second chamber which are separated by a non-permanent peel seal, wherein the first chamber contains a composition of amino acids and optionally electrolytes, and wherein the second chamber contains a dextrose solution, and wherein the product is characterized by a high protein (nitrogen) content per volume. The reconstituted solution is configured to be administered peripherally or centrally for the treatment of patients suffering from malnutrition and/or having a need for increased uptake of amino acids.

PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT

The present disclosure relates to a sterile medical product for parenteral nutrition comprising a polymeric container having at least a first and a second chamber which are separated by a non-permanent peel seal, wherein the first chamber contains a composition of amino acids and optionally electrolytes, and wherein the second chamber contains a dextrose solution, and wherein the product is characterized by a high protein (nitrogen) content per volume. The reconstituted solution is configured to be administered peripherally or centrally for the treatment of patients suffering from malnutrition and/or having a need for increased uptake of amino acids.

Carrier for carrying a container of medically useful solution or suspension
11737953 · 2023-08-29 ·

A supple carrier for carrying a container of medically useful solution or suspension. The supple carrier includes a first monitoring window providing a first visualization perspective of the container contained by the envelope and one or more adjustable pressurizers. The supple carrier can delay the temperature change of the medically useful solution or suspension carried by the carrier.

Carrier for carrying a container of medically useful solution or suspension
11737953 · 2023-08-29 ·

A supple carrier for carrying a container of medically useful solution or suspension. The supple carrier includes a first monitoring window providing a first visualization perspective of the container contained by the envelope and one or more adjustable pressurizers. The supple carrier can delay the temperature change of the medically useful solution or suspension carried by the carrier.